Deep learning radiomics fusion model to predict visceral pleural invasion of clinical stage IA lung adenocarcinoma: a multicenter study.

AIM: To assess the predictive performance, risk stratification capabilities, and auxiliary diagnostic utility of radiomics, deep learning, and fusion models in identifying visceral pleural invasion (VPI) in lung adenocarcinoma.

MATERIALS AND

METHODS

A total of 449 patients (female:male, 263:186; 59.8 ± 10.5 years) diagnosed with clinical IA stage lung adenocarcinoma (LAC) from two distinct hospitals were enrolled in the study and divided into a training cohort (n = 289) and an external test cohort (n = 160). The fusion models were constructed from the feature level and the decision level respectively. A comprehensive analysis was conducted to assess the prediction ability and prognostic value of radiomics, deep learning, and fusion models. The diagnostic performance of radiologists of varying seniority with and without the assistance of the optimal model was compared.

RESULTS

The late fusion model demonstrated superior diagnostic performance (AUC = 0.812) compared to clinical (AUC = 0.650), radiomics (AUC = 0.710), deep learning (AUC = 0.770), and the early fusion models (AUC = 0.586) in the external test cohort. The multivariate Cox regression analysis showed that the VPI status predicted by the late fusion model were independently associated with patient disease-free survival (DFS) (p = 0.044). Furthermore, model assistance significantly improved radiologist performance, particularly for junior radiologists; the AUC increased by 0.133 (p < 0.001) reaching levels comparable to the senior radiologist without model assistance (AUC: 0.745 vs. 0.730, p = 0.790).

CONCLUSIONS

The proposed decision-level (late fusion) model significantly reducing the risk of overfitting and demonstrating excellent robustness in multicenter external validation, which can predict VPI status in LAC, aid in prognostic stratification, and assist radiologists in achieving higher diagnostic performance.